E37: Errik Anderson on Co-Founding 20 Biotech Startups Cumulatively Worth $10B+

Errik Anderson sits down with David Weisburd to discuss Pro-noia, the potential of the biotech industry, and the 82VS Seed Fund investment approach. They discuss practicing Pro-noia, the value of building a portfolio of relationships, and the idea of a forever company.

Speakers

AI Chat

Errik Anderson

Guest • 85%

David Weisburd

Host • 14%

David Weisburd

Host • 1%

Chapters

0:00	Introduction to Errik Anderson and his concept of Pro Noya
10:22	The potential scale of platform building in the biotech industry
20:22	Leading with work and following with capital - the approach at 82VS Seed Fund
28:13	Practicing Pro Noya: Cultivating optimism and generosity
33:35	Building a portfolio of relationships and the compounding value
40:01	Errik Anderson on involving his family in his work
46:00	Errik Anderson's management style: micro-managing or detailed involvement?
54:09	Errik Anderson explains the concept of a forever company
57:00	Collaborating with big pharmaceutical companies like Pfizer
1:00:56	Launch of the Tenex Capital Podcast newsletter powered by Carrie Alabs

Transcript

Clip

Loading transcript...